Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

Keyphrases

• Antiviral Response 100%
• Chemokines 50%
• COVID-19 100%
• CXCL10 25%
• CXCL13 25%
• Cytokines/chemokines 25%
• Disease Progression 25%
• Fatal Infection 50%
• IL-12p70 25%
• Immune Response 25%
• Inflammatory Response 25%
• Initial Infection 25%
• Interferon-α (IFN-α) 75%
• Interleukin-10 25%
• Interleukin-2 25%
• Mucosa 25%
• Mucosal Cytokines 25%
• Mucosal Immune Response 50%
• Mucosal Inflammation 25%
• Mucosal Response 25%
• Mucosal Sites 25%
• Nasal Samples 25%
• Non-associated 25%
• Onset Phase 25%
• Peripheral Blood 50%
• Peripheral Inflammation 100%
• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) 25%
• Severe Acute Respiratory Syndrome Coronavirus 2 Infection 25%
• Severe Coronavirus Disease 2019 50%
• Symptom Onset 50%
• Upper Respiratory Tract 25%
• Viral Load 50%

Immunology and Microbiology

• Chemokine 50%
• COVID-19 100%
• CXCL10 16%
• CXCL13 16%
• Cytokine 50%
• Immune Response 16%
• Infection 50%
• Infectious Disease 50%
• Inflammation 100%
• interferon 50%
• Interleukin 10 16%
• Interleukin 2 16%
• Mucosa 16%
• Mucosal Immune Response 33%
• Severe Acute Respiratory Syndrome Coronavirus 2 33%
• Viral Load 33%